Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhongjun Ma

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Biomaterials|June 15, 2021
Tumor progress intercept by intervening in Caveolin-1 related intercellular communication via ROS-sensitive c-Myc targeting therapyXueqing Zhou, Xuan Liu, Xiqin Yang, et al.
Oncotargets and Therapy|January 20, 2021
<i>Physalis alkekengi</i> var. <i>franchetii</i> Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 SignalingYufei Fu, Fanfan Zhu, Zhongjun Ma, et al.
Journal of Medicinal Chemistry|August 7, 2024
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast CancerXiaoming Chen, Xia Ding, Jiebin Fang, et al.
Ecotoxicology and Environmental Safety|February 14, 2025
Transgenerational toxicity assessment of [C<sub>8</sub>mim]Br: Focus on early development, antioxidant defense, and transcriptome profiles in zebrafishFei Zhao, Ying Shen, Zhongjun Ma, et al.
European Journal of Medicinal Chemistry|February 10, 2023
Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasisJinhui Wang, Tingting Gao, Yijun Ma, et al.
Journal of Medicinal Chemistry|November 11, 2024
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor ImmunityChuru Mao, Jiebin Fang, Shijie Zou, et al.
Biology Methods & Protocols|March 28, 2024
A rapid and accurate method for evaluating the degradation of pan-Akt in cells by PROTACs using NanoLuc luciferaseXiaojun Ji, Lei Miao, Yebin Wu, et al.
Journal of Medicinal Chemistry|October 26, 2020
Identification, Structure-Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer EfficacyJinhui Wang, Weiyang Jin, Xiaoxin Zhou, et al.
Scientific Reports|August 27, 2017
Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia KansuiPengfei Wang, Panpan Lu, Xiying Qu, et al.
Toxicology and Applied Pharmacology|October 9, 2020
Physapubescin B enhances the sensitivity of gastric cancer cells to trametinib by inhibiting the STAT3 signaling pathwayChunyan Dai, Li Shen, Weiyang Jin, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Biomaterials|June 15, 2021
Tumor progress intercept by intervening in Caveolin-1 related intercellular communication via ROS-sensitive c-Myc targeting therapyXueqing Zhou, Xuan Liu, Xiqin Yang, et al.
Oncotargets and Therapy|January 20, 2021
<i>Physalis alkekengi</i> var. <i>franchetii</i> Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 SignalingYufei Fu, Fanfan Zhu, Zhongjun Ma, et al.
Journal of Medicinal Chemistry|August 7, 2024
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast CancerXiaoming Chen, Xia Ding, Jiebin Fang, et al.
Ecotoxicology and Environmental Safety|February 14, 2025
Transgenerational toxicity assessment of [C<sub>8</sub>mim]Br: Focus on early development, antioxidant defense, and transcriptome profiles in zebrafishFei Zhao, Ying Shen, Zhongjun Ma, et al.
European Journal of Medicinal Chemistry|February 10, 2023
Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasisJinhui Wang, Tingting Gao, Yijun Ma, et al.
Journal of Medicinal Chemistry|November 11, 2024
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor ImmunityChuru Mao, Jiebin Fang, Shijie Zou, et al.
Biology Methods & Protocols|March 28, 2024
A rapid and accurate method for evaluating the degradation of pan-Akt in cells by PROTACs using NanoLuc luciferaseXiaojun Ji, Lei Miao, Yebin Wu, et al.
Journal of Medicinal Chemistry|October 26, 2020
Identification, Structure-Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer EfficacyJinhui Wang, Weiyang Jin, Xiaoxin Zhou, et al.
Scientific Reports|August 27, 2017
Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia KansuiPengfei Wang, Panpan Lu, Xiying Qu, et al.
Toxicology and Applied Pharmacology|October 9, 2020
Physapubescin B enhances the sensitivity of gastric cancer cells to trametinib by inhibiting the STAT3 signaling pathwayChunyan Dai, Li Shen, Weiyang Jin, et al.
Pageof 11